mzbaptista.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

[email protected] engages in judicial and legislative advocacy to protect NIH funding: www.asco.org/news-initiat...

submitted 4 days ago • 0 comments

What a great start to 2025 having our review on the role of hashtag#CDKs in human physiology and diseases just published in #Signal_Transduction_Targeted_Therapies! Here is the link to the open access article 👇 rdcu.be/d6a4g A big effort of the lab but we learnt a lot! I hope you will enjoy it

submitted 45 days ago • 0 comments

The OncoAlert🚨 Network along with our partners invite you to the #OncoAlertColloquium REGISTER for FREE HERE👉 https://buff.ly/3CChgre February 3-9, 2025 💯% Virtual& Interactive Watch Our #BreastCancer Faculty @hoperugo.bsky.social 🇺🇸 Presenting on Advanced TNBC Year in Review

submitted 35 days ago • 0 comments

🎉 MedNews Week Turns 3! 🎉 Earlier this month, MedNews Week celebrated its 3rd anniversary! 🥳 We are deeply grateful to our incredible Keynote Speakers for supporting our mission to advance global medical education and combat misinformation. 🌍📚

submitted 65 days ago • 2 comments

Interesting new study looking at screening colonoscopy intervals and individual's risk profiles - >10 years may be optimal with lower risk jamanetwork.com/journals/jam...

submitted 70 days ago • 0 comments

OUR COMPLETE #SABCS24 🚨Newsletter IS OUT REGISTER at oncoalert360.com OR buff.ly/48Xpgz0 This Includes all of OUR TOP pick of TRIALS presented during these last 4 days in San Antonio & Video Interviews from our Collaborators at @vjoncology.bsky.social and high5md

submitted 74 days ago • 1 comment

📣 ASCO is now here 🦋! @ascocancer.bsky.social @ascopost.bsky.social #OncSky #AcademicSky #MedSky #Oncology #CancerResearch @oncoalert.bsky.social @oncodaily.bsky.social @onclive.bsky.social

submitted 76 days ago • 3 comments

The OncoAlert 🚨Newsletter NOW OUT Covering September November 28-Dec 5, 2024 REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0 ✅FDA Approves Duvalumab in #SCLC 🫁🇺🇸 ✅FDA ACCELERATED APPROVAL TO ZENOCUTUZUMAB-ZBCO IN #NSCLC 🫁 ✅Lung adenocarcinomas with mucinous & more

submitted 85 days ago • 1 comment

Good info here from CA: A Cancer Journal for Clinicians. Content is free, year round! Happy holidays as we buckle in for a tumultuous few years.

submitted 87 days ago • 0 comments

SONIA trial - Pts with ER+ breast cancer beginning treatment in the metastatic setting randomized to 1st line vs 2nd line use of CDK4/6 inhibitor (+ endocrine therapy). No sig difference in PFS. www.nature.com/articles/s41...

submitted 91 days ago • 1 comment

Thanks @tmprowell.bsky.social Will take this off social and send to our fellows. Such a great opportunity. it cannot live in the sky alone.

submitted 93 days ago • 0 comments

Now in JNCI “Pts w stage 1 & 2 breast cancer have excellent prognosis, yet account for >60% breast cancer–specific death due to large #. To ⬇️ breast cancer death, strategies neededed to identify,treat pts w/early stage BC w/ risk for recurrence” @oncoalert.bsky.social doi.org/10.1093/jnci...

submitted 96 days ago • 1 comment

Vote in the ASCO Election - now through December 3 Help ASCO choose the Society’s future leaders, plus earn a point toward FASCO designation for voting! society.asco.org/about-asco/a...

submitted 97 days ago • 0 comments

The ASCO25 abstract submitter:

submitted 97 days ago • 0 comments

Thanks for posting! A favorite activity is the recordings I do with Sara Tolaney around new data at our international meetings! @oncoalert.bsky.social @ucsfcancer.bsky.social

submitted 97 days ago • 0 comments

📣JUST IN: Dr. Sara Tolaney @danafarber.bsky.social BreastOnc & Dr. Hope Rugo @hoperugo.bsky.social UCSFCancer share insights on Top #SABCS24 abstracts! Watch 📽️ on 👇 tinyurl.com/SABCS24eBC #bcsm #oncsky #medsky #breastcancer

submitted 98 days ago • 0 comments

Since #oncsky is forming here just wanted to post about the origins of the healthcare hashtags, all of which used "sm" to anchor = social media jamanetwork.com/journals/jam... 1/3

submitted 98 days ago • 2 comments

OncoAlert🚨 RoundUp September Nov 14-21 REGISTER: www.OncoAlert360.com OR buff.ly/48Xpgz0

submitted 98 days ago • 0 comments

Genomic Profiling Improves Precision Therapy Use & Survival - 2/3rds patients w/advanced cancer candidates for precision therapies -In patients with sufficient follow-up, those receiving targeted therapies had median OS 25 months vs 17 months w/chemo alone dailynews.ascopubs.org/do/comprehen...

submitted 101 days ago • 1 comment

Ethical considerations of Next generation sequencing Excellent summary- ascopubs.org/doi/pdf/10.1...

submitted 104 days ago • 0 comments

Surveyed surviving caregivers had worse experiences including lower ratings for timely care & symptom management when their loved one died in hospices owned by private equity firms. 🏥💸⚕️More evidence that, when you run healthcare like a business, people suffer. jamanetwork.com/journals/jam...

submitted 101 days ago • 1 comment

All I can tell you Is that all of our OncoAlert 🚨content for #SABCS24 will be shared in BlueSky as well as Twitter. 100% and thats a promise we make to our Colleagues! #BreastCancer #BCSM

submitted 101 days ago • 1 comment

OncoAlert along with our partners at ESSO, ESGO, MASCC & SIOG Proudly Announce 1/3 of our faculty, more soon@ Register HERE https://buff.ly/3CChgre @elisabettabonzano.bsky.social @elisaagostinetto.bsky.social @realbowtiedoc.bsky.social @erikahamilton9.bsky.social @agerikssonmd.bsky.social

submitted 101 days ago • 0 comments

Impact of risk reducing surg for young women with BRCA (Lambertini). Zest (Turner) about ctDNA in high risk early stage disease, what have we learned! of course many more... @oncoalert.bsky.social

submitted 101 days ago • 0 comments

Updated treatment algorithms for breast cancer now include adjuvant ribociclib and inavolisib, along with key trial names. Thrilled to see we're truly running out of space in HR+ disease—progress is here, with much more to come for all breast cancer subtypes!

submitted 103 days ago • 3 comments

Retrospective study aims to evaluate effectiveness and safety of immune checkpoint inhibitors in Black patients, who were underrepresented in clinical trials leading to ICIs’ approval.Findings suggest Black pts may have a more favorable therapeutic ratio for ICI treatment https://buff.ly/4fBgtpa

submitted 103 days ago • 0 comments

The OncoAlert 🚨Weekly RoundUp Covering September November 8-14, 2024 REGISTER AT oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

submitted 104 days ago • 1 comment

Just Released! Did Michelangelo paint a young adult woman with breast cancer in “The Flood", Sistine Chapel, Rome? 📣 Check out this recently published paper in The Breast @sciencedirect 📚🔬 #bcsm #BreastCancerResearch 👉 www.sciencedirect.com/science/arti...

submitted 104 days ago • 0 comments

Dear Colleagues, For all of you in BlueSky, Greetings, We are Now Here!! We invite you to Join & Follow OncoAlert at @oncoalert.bsky.social Thank you for your support!

submitted 104 days ago • 1 comment